The Prevalence of Hemoglobinopathies in Premarriage Men Referred to the Laboratories of Health Centers in the Shushtar City

Document Type : Original Article


1 Department of Clinical Biochemistry, Faculty of Medicine, Jundishapur University of Medical Sciences, Ahvaz, Iran.

2 -Department of Laboratory Sciences, School of Paramedical Sciences, Jundishapur University of Medical Sciences, Ahvaz, Iran.

3 Department of Hematology, School of Paramedical Sciences, Jundishapur University of Medical Sciences, Ahvaz, Iran.

4 Department of Hematology, School of Paramedical Sciences, Mashhad University of Medical Sciences, Mashhad, Iran.


Background and Objective: Hemoglobinopathies are the most common monogenic disorders with remarkable frequency in certain regions of the world, including Iran. At least 5.2% of world population is carrier for a main hemoglobin (Hb) disorder. More than 900 Hemoglobin variants were reported due to globin gene mutations that cause structural changes in globin gene products which ultimately affect the performance and stability of hemoglobin. The aim of this study was to evaluate the prevalence of hemoglobinopathies in premarriage men referred to the laboratories of Health Centers in the Shushtar City during the years 2011-2013.
Subjects and Methods:  Hematological parameters in blood samples containing EDTA were measured by Hematology Analyzer (Sysmex KX-21). Hemoglobin electrophoresis was performed by Sebia capillary electrophoresis and types of hemoglobinopathies were determined.
Results: 111 casesfrom total 8806 cases were has abnormal bands of hemoglobin. From this total, 3 cases (0.03%) were with heterozygous hemoglobin E and 1 case (0. 01%) was heterozygous hemoglobin C. Also, 74 cases (0.84%) had hemoglobin D, and 28 patients (0.32%) containing hemoglobin S were with different genotype status; homozygous or heterozygous types. In this study, uncommon Hemoglobin variants (with the prevalence of 0.05%) such as hemoglobin O- Arab and constant spring was observed.
Conclusion: This study showed that from 8806 individuals, 111 subjects (1.25%) have hemoglobinopathies. HbD with 0.84% and HbC with 0. 01% of total have highest and minimum frequency.


1-Christianson A, Howson C, Modell C. March of Dimes Global Report on Birth Defects: The Hidden Toll of Dying and Disabled Children. Newyork: Whaite plains; 2006.
2-Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Org 2008 Jun; 86(6): 480-7.
3-Bahoush KAMFG, Ansari PVAHS, Shahgholi E. Study of D/G Hemoglobin incidence in a sample population (single institution). Int J Hematol Oncol Stem Cell Res 2005; 2(1): 23-5.
4-Rahimi Z. Genetic epidemiology, hematological and clinical features of hemoglobinopathies in Iran. Biomed Res Int 2013; 2013: 1-10.
5-Hoffbrand AV, Catovsky D, Tuddenham EG. Postgraduate haematology. USA: John Wiley & Sons; 2008.
6-Forget BG, Bunn HF. Classification of the Disorders of Hemoglobin. Cold Spring Harb Perspect Med 2013 Feb; 3(2): a011684.
7-Elison Hirsch R, Roche CJ, Friedman JM. P57: HbE/β-thalassemia associated pathophysiology: Mechanisms originating from reduced HbE nitrite reactivity. Nitric Oxide 2013; 31 Supll 1: S37.
8-Nussbaum R, McInnes RR, Willard HF. Thompson & Thompson genetics in medicine. Philadelphia: Elsevier Health Sciences; 2007.
9-Clarke GM, Higgins TN. Laboratory investigation of hemoglobinopathies and thalassemias: review and update. Clin chem 2000 Aug; 46(8): 1284-90.
10-Weatherall DJ, Clegg JB. The thalassaemia syndromes. USA: John Wiley & Sons; 2008.
11-Ashtiani M, Monajemzadeh M, Sina A, Berenji F, Abdollahi M, Said M, "et al". Prevalence of haemoglobinopathies in 34 030 healthy adults in Tehran, Iran. J Clin Pathol 2009; 62(10): 924-5.
12-Zakerinia M, Ayatollahi M, Rastegar M, Amanat S, Askarinejad A, Amirghofran S, "et al". Hemoglobin D (Hb D Punjab/Los Angeles and Hb D Iran) and Co-Inheritance with Alpha-and Beta-Thalassemia in southern Iran. Iran Red Crecent Med J 2011 Jul; 13(7): 493-8.
13-Zandian KM, Pedram M, Hamadi H. AN Analysis of Clinical and Laboratory Findings of Hemoglobinopathis and Their Distribution in Khozestan Province. Sci Med J 2005; 43(7):1.
14-Movahed A, Obeidi N. Prevalence of Hemoglobinopathies and their associations with different types of hemoglobin and mean cell volume in the preuniversity students of Bushehr, 2007. ISMJ 2009;12(1): 54-9.
15-Valizadeh F, Mousavi A, Hashemi-Soteh M. Prevalence of hemoglobinopathies in premarriage individuals referred to Babolsar, Iran (2006-09). J Gorgan Uni Med Sci 2012;14(1): Pe106-Pe11, En12.
16-Dehghanifard A, Kaviani S, Noruzinia M, Soleimani M, Abroun S, Hajifathali A, "et al". Synergistic effect of sodium butyrate and thalidomide in the induction of fetal hemoglobin expression in erythroid progenitors derived from cord blood CD133+ cells. Zahedan J Res Med Sci 2012; 14(7): 29-33.
17-Rahimi Z, Parsian A. Sickle cell disease and venous thromboembolism. Mediterranean J Hematol Infect Dis 2011; 3(1): e2011024.